High expression of serine and arginine-rich splicing factor 9 (SRSF9) is associated with hepatocellular carcinoma progression and a poor prognosis

• Main Authors: Guoshun Zhang (Author), Bin Liu (Author), Hua Shang (Author), Guikai Wu (Author), Diyang Wu (Author), Liuqing Wang (Author), Shengnan Li (Author), Zhiyuan Wang (Author), Suying Wang (Author), Juxiang Yuan (Author)
• Format: Book
• Published: BMC, 2022-08-01T00:00:00Z.
• Subjects: article
• Online Access: Connect to this object online.

Highlights SRSF9 is a potential independent risk factor for HCC. High methylation status of cg06116271 predicted a better prognosis in HCC. SRSF9 knockdown inhibited the Wnt signaling pathway and cell cycle pathway. SRSF9 may serve as a potential therapeutic target for HCC.